Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molnova is a leading global supplier of bioactive small molecules and chemical reagents for life science research and drug discovery. The company offers a vast catalog of inhibitors, activators, and screening libraries targeting a wide range of signaling pathways and protein families. Molnova provides high-purity compounds to academic, pharmaceutical, and biotech researchers worldwide, supporting preclinical research across various therapeutic areas including oncology and immunology. Their services include custom synthesis and the provision of specialized chemical libraries for high-throughput screening. The company maintains rigorous quality control standards, ensuring the identity and purity of their products through NMR and HPLC analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molnova.